Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice. - Concepedia

Concepedia

Publication | Closed Access

Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice.

32

Citations

0

References

2017

Year

Yongyu Shi, Zhang Hz, Zhao Xy, Jian Jin, Wang Hy

Abstract

LXA4 has a protective effect against EAM by reducing the inflammatory response and inhibiting NF-κB and PI3K/Akt signaling pathway.